REMATIQ receives 5.4 million euros in seed financing

The Berlin-based startup is developing a platform that uses AI to automate and simplify compliance processes in medical technology.

Berlin, April 10, 2025 - The startup REMATIQ has raised 5.4 million euros in a seed financing round. The round is led by Project A Ventures, with other investors including Amino Collective, HelloWorld and business angels such as Boris Lokschin (Spryker Systems) and Timo Fleßner. REMATIQ is developing an AI-based platform that aims to automate and simplify compliance processes in medical technology.

AI-supported platform for product compliance

REMATIQ has developed an AI-native platform that analyzes regulatory documents and provides the requirements in real time. The aim is to integrate regulatory requirements directly into the development and quality processes of medical technology companies. According to the company, this can reduce the documentation effort by up to 90 percent and reduce the risk of non-compliance.

The volume and complexity of international regulations is constantly growing.

Mandy Blocher, Head of PLM Digitalization & Regulatory Intelligence at the B. Braun Group

"The volume and complexity of international regulations is constantly growing. We feel this in our day-to-day work - in development as well as in clinical evaluation, approval and market observation. An AI-based approach such as that of REMATIQ starts exactly where the leverage is greatest," says Mandy Blocher, Head of PLM Digitalization & Regulatory Intelligence at the B. Braun Group, one of the partner companies.

Capital for technological development and expansion

REMATIQ intends to invest the newly raised capital primarily in the further development of its AI technology and the expansion of the development team. The focus is also on international expansion, particularly in Europe and the USA.

Regulatory requirements should not slow down innovation, but accelerate it

David Boutellier, Co-Founder and CEO of REMATIQ

The investors are also convinced: "REMATIQ hits the nerve of the industry," says Anton Waitz, General Partner at Project A. The platform increases efficiency in regulated markets without compromising on quality and safety.

REMATIQ was founded in 2023 by David Boutellier and Florian Scherer. The platform uses artificial intelligence to translate complex regulatory requirements - for example from FDA or MDR guidelines - into clear, applicable tasks and integrate them directly into company processes.